GOOD DAY FOR: A drug war, as Pfizer, the world’s largest drugmaker, is considering a counteroffer for Indian generics giant Ranbaxy Laboratories, the Business Standard newspaper reported. Japan’s Daiichi Sankyo bid $4.6 billion for Ranbaxy earlier this week. A Ranbaxy spokesman called the report “speculation,” adding, “We have a binding contract with Daiichi. It is a final contract.” (Reuters)
BAD DAY FOR: Overpacking, after United Airlines and US Airways both said they will charge $15 for passengers’ first checked bag, following American Airlines’ lead. Most U.S. airlines, except for Southwest, already charge $25 for checking a second piece of luggage. US Airways also said it will cut 1,700 jobs, shrink its fleet, and start charging for all in-flight beverages. (AP in Yahoo! Finance)
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Andor series two: a 'perfect' Star Wars showThe Week Recommends Second instalment of Tony Gilroy's 'compelling' spin-off is a triumph
-
The rise and fall of 4chanThe Explainer Most notorious messageboard on the internet appears to have posted its last meme
-
Protein obsession is oversaturating the health food spaceUnder the Radar Some experts say that fiber is now the most important macro to focus on
